GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (STU:L74) » Definitions » Total Stockholders Equity

WuXi XDC Cayman (STU:L74) Total Stockholders Equity : €870.9 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman Total Stockholders Equity?

WuXi XDC Cayman's Total Stockholders Equity for the quarter that ended in Dec. 2024 was €870.9 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. WuXi XDC Cayman's Book Value per Share for the quarter that ended in Dec. 2024 was €0.73. The ratio of a company's debt over equity can be used to measure how leveraged this company is. WuXi XDC Cayman's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.07.


WuXi XDC Cayman Total Stockholders Equity Historical Data

The historical data trend for WuXi XDC Cayman's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman Total Stockholders Equity Chart

WuXi XDC Cayman Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Total Stockholders Equity
47.22 2.90 200.50 700.49 870.89

WuXi XDC Cayman Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Stockholders Equity Get a 7-Day Free Trial 200.50 218.93 700.49 767.19 870.89

WuXi XDC Cayman  (STU:L74) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

WuXi XDC Cayman's Book Value per Share for the quarter that ended in Dec. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

WuXi XDC Cayman's Debt-to-Equity for the quarter that ended in Dec. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WuXi XDC Cayman Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of WuXi XDC Cayman's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


WuXi XDC Cayman Business Description

Traded in Other Exchanges
Address
No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN
WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.

WuXi XDC Cayman Headlines

No Headlines